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Objective: To understand doctors’ attitude to and awareness of AYUSH therapies for the
treatment of diabetes mellitus (DM).
Methods: This qualitative study, using a usage-and-attitude survey, was conducted in secondary
centers across Mumbai, India. The study surveyed 77 physicians, including those specializing in
diabetes.
Results: Themajority of doctors were aware of Ayurveda (69%) andHomeopathy (52%). Some
doctors were aware of Unani (34%) and Siddha (32%). Most doctors (60%) thought that
Ayurveda was effective in some way. Almost all doctors (97%) thought that allopathic medicine
was effective for DM. Themajority of doctors (68%) had not recommendedAYUSH therapies as
an adjunct to modern medicines. Approximately half of the doctors (52%) believed that AYUSH
therapies posed a safety concern for patients and 46% thought that AYUSH therapies could not
be used to manage any form of DM. A large group of doctors thought that the main barrier
preventing AYUSH therapies from being integrated into current allopathic management of DM
was the lack of strong scientiﬁc evidence and clinical trials.
Conclusion: The majority of doctors are aware to some degree of Ayurveda and homeo-
pathic forms of treatment. The majority believe that AYUSH therapies pose a safety concern
for patients and have no role in treatment for any form of DM. The most common barrier
preventing AYUSH therapies from becoming a mainstream treatment option for DM is the
lack of scientiﬁc evidence. From this sample, it seems that greater efforts are required to
conduct research into the efﬁcacy and safety of AYUSH therapies to ensure that doctors are
able to provide holistic care for patients with DM.
Keywords: diabetes mellitus, complementary medicine, public health, governmental policy,
patient care
Background
Diabetes mellitus (DM) is a disorder characterized by insulin deﬁciency,
increased glycemic levels and insulin resistance. DM has reached pandemic propor-
tions and has become a major health concern in India. Epidemiological studies have
shown an increase in the prevalence of DM in both city and rural populations. The
diabetes prevalence increased from 5% in 1985 to 18.6% in 2006 in cities, and from
2.2% in 1989 to 9.2% in 2006 in rural areas.1 It is estimated that currently more than
30 million individuals are living with either undiagnosed or untreated DM, thus
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increasing the risk of developing complications and prema-
ture mortality. The mainstay of treatment for type 1 DM
involves insulin therapy, whereas a combination of pharma-
cological therapies and changes to lifestyle and diet are
advocated for managing type 2 DM. The economic burden
of diabetic care on families in developing countries, includ-
ing India, is rising rapidly. Treatment costs for patients in
India are increased with the duration of diabetes, presence
of complications, hospitalization, surgery, insulin therapy
and urban setting.
India has a population of more than a billion people and is
home to some of the most diverse cultural and religious
groups in the world. Owing to wide disparities in wealth,
education and access to healthcare, some of these cultural
groups still utilize alternate forms of medicine. The
Ayurveda, Unani, Siddha, Homeopathy (AYUSH) therapies
are one of the oldest forms of alternate medicines in India,
originating approximately 2000 years ago. The Indian system
of medicine still recognizes AYUSH as a form of medical
treatment.2 The Government of India has a dedicated
Ministry, established in 2014, to ensure the optimal develop-
ment and propagation of the AYUSH system of healthcare.
Ayurveda (the science of life) incorporates all aspects
of life, whether physical, psychological, spiritual or social.
In Ayurveda, DM is termed Madhumeha (honey urine),
and advocates the use of a variety of herbal preparations,
such as decoctions, juices and powders, for treatment. All
of these are of plant origin and have not yet seen reports of
any adverse effects in therapeutic doses. However, they
may contain animal and inorganic products.3 The founda-
tion of the Unani system in India stems from the Perso-
Arabic system of health. Unani bases its theory of illness
on the imbalances between certain ﬂuids (e.g. bile and
blood) in the human body. Siddha is currently practiced
mainly in the southern regions of India and focuses on
maintaining equilibrium between the environment, cli-
matic conditions, physical activities and stress, to ensure
good health. Finally, Homeopathy is an increasingly used
system that is known to be practiced globally. It is esti-
mated that about 10% of the Indian population depend
solely on Homoeopathy for their healthcare needs, and it
is considered the second most popular system of medicine
in the country.4 Its strength lies in its evident effectiveness,
as it takes a holistic approach towards the sick individual
through the promotion of inner balance at the mental,
emotional, spiritual and physical levels.
As the incidence of DM is rapidly increasing through-
out India, might the AYUSH therapies play a role in
controlling this epidemic? Could AYUSH therapies be
used as an adjunct alongside modern medicine to provide
psychological support to patients and increase adherence
to modern medicine? In this study, we aim to explore how
doctors in India’s largest city, Mumbai, perceive the use of
AYUSH therapies for treating DM, and whether they
advocate them to their patients and believe that this form
of treatment has any place alongside modern medicine.
Methods
Patient and Public Involvement
This research was inspired by the large use of AYUSH
therapies among the Indian population. No patients were
involved in any phases of this study since we wanted
solely to attempt to understand the perception of allopathic
doctors. The results of this study will be emailed to the
doctors who kindly participated in the research.
Participants
A total of 77 doctors were surveyed, which included those
with only a degree in Bachelor of Medicine, Bachelor of
Surgery (MBBS) (n=31), those with a further postgraduate
degree in Doctor of Medicine (MD) (n=37) and those with
further training and specializing in diabetes (n=9). These
physicians worked across 18 different centers in suburban
and greater Mumbai.
Procedure
A snowball sampling method was used and participants
were approached personally at their clinic. No prior rela-
tionship was established between the doctors and research
group, and the participants had no knowledge of the inter-
viewers’ background. All participants were made aware
that the purpose of this survey was to understand their
awareness and perception of the topic, and that at no point
any data would be collected or presented that would reveal
any of their identities. Surveys were therefore only con-
ducted if the participants gave their consent.
A pilot questionnaire was tested to assess its coherence
and guidance was provided to the doctors to allow them to
complete the questionnaire without confusion. Students
based in India conducted the interview at the doctors’
clinics for 30 min. No other individuals except for the
interviewer and the doctor were present during the pro-
cess. The survey was not recorded in either audio or visual
format. Moreover, repeat interviews were not carried out.
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Each doctor was asked a ﬁxed set of questions and
a questionnaire was ﬁlled in. All doctors were asked to
validate their response by providing their signature at the
end of the physical questionnaire.
The questionnaire used a Likert scale to record the
following elements:
● Awareness of the different systems of AYUSH therapies
● Perception of the effectiveness of the different
systems of AYUSH therapies
● Attitudes towards using AYUSH therapies as an
adjunct to modern medicine
● Attitudes towards the existing evidence for AYUSH
therapies
● Opinion on the main factor preventing AYUSH thera-
pies from becoming a primary treatment option for DM.
For further analysis and comparison, each statement on the
Likert scale was assigned a numerical value ranging from
1 to 5.
Results
Awareness of the Different Systems of
AYUSH Therapies
In total, 53 doctors (69%) were slightly to extremely aware of
Ayurveda,with the remainder being not at all aware; 25 doctors
were slightly to extremely aware of Siddha (32%),with the rest
(68%) being not at all aware; 26 doctors (34%)were slightly to
extremely aware of Unani, with the others (66%) being not at
all aware; and ﬁnally, 40 doctors (52%) were slightly to extre-
mely aware of Homeopathy, with the remainder (48%) being
not at all aware. Table 1 shows the full breakdownof awareness
for each system. Each of the options, “Not at all aware”,
“Slightly aware”, “Somewhat aware”, “Moderately aware”
and “Extremely aware”, was assigned a numerical score of 1,
2, 3, 4 and 5, respectively, and scores were subsequently tallied
and compared. Out of a maximum score of 385, the scores for
each component were: Ayurveda199, Siddha 130, Unani 135
and Homeopathy 170 (Figure 1).
Perception of the Effectiveness of the
Different Systems of AYUSH Therapies
In total, 46 doctors (60%) perceived Ayurveda to be slightly to
extremely effective, with the remainder (44%) believing it to
be not at all effective; 22 doctors (29%) thought Siddha was
slightly to extremely effective, with the rest (71%) thinking
that it was not at all effective; 23 doctors (30%) believedUnani
to be slightly to extremely effective, with the others (70%)
believing it to be not at all effective; 38 doctors (41%) per-
ceived Homeopathy to be slightly to extremely effective, with
the rest (51%) believing it to be not at all effective. Finally, an
additional option of “allopathic medicine” was given to com-
pare against AYUSH therapies, and 75 doctors (97%) thought
that allopathic medicine was slightly to extremely effective
and two (3%) thought that it was not at all effective. Table 2
shows the breakdown of doctors’ perceptions for each com-
ponent. Each of the options, “Not at all effective”, “Slightly
effective”, “Somewhat effective”, “Moderately effective” and
“Extremely effective”, was assigned a numerical scores of 1,
2, 3, 4 and 5, respectively, and scores were subsequently tallied
and compared. Out of a maximum score of 385, the score for
each component were: Ayurveda 176, Siddha 126, Unani 120,
Homeopathy 152 and allopathic medicine 350 (Figure 2).
Attitudes Towards Using AYUSHTherapies
as an Adjunct to Modern Medicine
In total, 52 doctors had never recommendedAYUSH therapies
as an adjunct to allopathic medication. Of these doctors, 27
claimed to base their choice on scientiﬁc decisions and 25 did
not claim that their decision was evidence based. Table 3
shows the breakdown of doctors’ recommendations of
AYUSH therapies.
Table 1 Results for Awareness of Different Systems
Absolute Frequency (Total %)
Ayurveda Siddha Unani Homeopathy
Not at all aware 24 (31.2) 52 (67.5) 51 (66.2) 37 (48.0)
Slightly aware 14 (18.2) 7 (9.1) 7 (9.1) 10 (13.0)
Somewhat aware 13 (16.9) 6 (7.8) 8 (10.4) 11 (14.3)
Moderately aware 22 (28.6) 10 (13) 9 (11.7) 15 (19.5)
Extremely aware 4 (5.2) 2 (2.6) 2 (2.6) 4 (5.2)
Total 77 (100) 77 (100) 77 (100) 77 (100)
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Attitudes Towards the Existing Evidence
for AYUSH Therapies
When doctors were asked whether AYUSH therapies posed
a safety concern, 52% answered “yes”, 17% answered “no”,
and 31% were unsure and opted for “maybe” (Figure 3A).
When doctors were asked which form of DM AYUSH thera-
pies could be used for, the majority (46%) opted for “none”,
and the next largest group (22%) chose type 2 DM. Figure 3B
shows the full breakdown of doctors’ thoughts on AYUSH
therapy for each form of DM. Doctors were further asked
whether AYUSH therapies positively impacted a patient’s
quality of life: 22% answered “yes“, 26% said “no“ and
the remaining 52% were unsure and opted for “maybe”
(Figure 3C). Finally, doctors were asked what, in their opinion,
was themain factor preventingAYUSH therapies frombecom-
ing the main treatment option for DM. The majority cited
a lack of strong scientiﬁc evidence. Other popular
responses included lack of awareness, lack of clinical trials
and patient acceptability (Figure 4).
Discussion
India is home to a diverse population with differing cultural
and religious beliefs. These cultures often have their own
ideologies with regard to managing diseases. In this study,
we aimed to explore whether allopathic doctors are aware of
these alternate forms of medicine, primarily AYUSH thera-
pies, and whether they believe that this form of treatment has
any place in current practice for the treatment of DM. Our
study found that doctors are aware of the different systems of
AYUSH therapies, with the majority being more aware of
Ayurveda and Homeopathy. However, doctors still believe
that allopathic medication is far more effective than AYUSH
therapies. More than 50% of doctors had never used AYUSH
therapies alongside allopathic treatment for DM and 46%
thought that AYUSH therapies cannot be used for any form
of DM. The main factor that doctors believed is preventing
AYUSH therapies from becoming a mainstream management
option is a lack of scientiﬁc evidence. However, 22% of
doctors thought that AYUSH therapies could have a positive
impact on patients’ quality of life, with a further 52%unsure of
their value in patient care.
One strength of our studywas the inclusion of doctors with
varying degrees of experience in clinical practice. This
allowed us to obtain results from different generations of
doctors, with varying knowledge of DM. Moreover, the doc-
tors worked across 18 different centers in suburban and greater
Table 2 Results for Doctors’ Perception Regarding the Effectiveness of Different Systems
Absolute Frequency (Total %) Allopathic Medicine
Ayurveda Siddha Unani Homeopathy
Not at all effective 31 (40.3) 55 (71.4) 54 (70.1) 39 (50.6) 2 (2.6)
Slightly effective 13 (16.9) 5 (6.5) 5 (6.5) 13 (16.9) 1 (1.3)
Somewhat effective 16 (20.8) 9 (11.7) 9 (11.7) 14 (18.2) 4 (5.2)
Moderately effective 14 (18.2) 6 (7.8) 7 (9.1) 10 (13) 16 (20.8)
Extremely effective 3 (3.9) 2 (2.6) 2 (2.6) 1 (1.3) 54 (70.1)
Total 77 (100) 77 (100) 77 (100) 77 (100) 77 (100)
Figure 1 Doctors’ awareness levels regarding AYUSH therapies for DM.
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Mumbai and therefore represented all income groups.
Conversely, India has over 4000 cities, and our study was
focused on one city and interviewed 77 doctors. Larger scale
studies in the other major cities in India could provide further
details on whether AYUSH therapies could be effectively
incorporated into current allopathic practice and for the man-
agement of DM. A study in New Delhi by Singhal and Roy5
investigated the awareness of and views on integrating
AYUSH therapies into modern medicine from 500 allopathic
doctors and 150 interns. The authors reported that 63% of
participants thought that AYUSH therapies were effective and
44% had recommended Homeopathy to their patients. These
results are in contrast to our study, where the majority had
never recommended any form of AYUSH systems, although it
must be noted that the previous study did not speciﬁcally look
into incorporating AYUSH in the management of DM.
Moreover, our study may have been biased based on the fact
that we only included allopathic doctors. Further analysis of
other healthcare professionals and those practicing non-
allopathic medicine could yield more diverse results and
allow us to factor in other aspects of AYUSH therapies that
may not have been raised during this study. Indeed, Ahmad
et al6 analyzed the perception of AYUSH therapies in 428
pharmacy students. The group reported that pharmacy stu-
dents held a favorable attitude and beliefs about AYUSH
use. Moreover, interviewing patients in India regarding the
effectiveness of AYUSH therapies could provide a more
patient-centered form of research into these systems of med-
icine. In our study, 26% of doctors thought that AYUSH
therapies did not positively impact patients’ quality of life.
A study to understand the perception of AYUSH therapies in
259 patients with DM by Ojha et al7 found that 43.6% of
patients thought that AYUSH therapies were effective in treat-
ing DM. Further analysis of perceptions in different healthcare
professionals and patients could open new avenues to incor-
porate AYUSH therapies into current practice and provide
holistic care to patients in India.
Our study showed that 30 doctors (39%) had either
“Never” or “Almost never” prescribed AYUSH therapies
based on scientiﬁc evidence. Furthermore, the most popu-
lar reason preventing AYUSH therapies being incorpo-
rated into modern practice was “lack of strong scientiﬁc
evidence”, with some doctors also giving “lack of clinical
trials” as a reason. These results are most surprising to us
because there is emerging evidence to suggest that
AYUSH therapies may help to control glycemic para-
meters. Studies carried out on streptozotocin-induced dia-
betic rats showed that an aqueous extract of Aegle
marmelos (considered “holy fruit trees” by Hindus) had
antiglycemic properties. Oral administration of this
Table 3 Results Demonstrating the Number of Doctors Who
Have Used AYUSH Therapies as an Adjunct to Modern Medicine
and Whether Their Decision Was Evidence Based
Recommended AYUSH Therapies as an
Adjuvant to Allopathic Medicine
Decision
Based on
Scientiﬁc
Evidence
Total
Yes No
Never 27 25 52
Almost never 3 0 3
Occasionally 17 2 19
Always 3 0 3
Figure 2 Doctors’ perception of effectiveness of the different AYUSH therapies and allopathic medicine for DM.
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Figure 3 (A) Attitudes towards AYUSH therapies and safety. (B) Attitudes towards use of AYUSH therapies for different forms of diabetes mellitus. (C) Attitudes towards
use of AYUSH therapies and their impact on quality of life.
Figure 4 Attitudes towards main factors preventing AYUSH therapies from becoming mainstream treatment options.
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compound was shown to decrease fasting blood glucose
levels by 61%.8 Moreover, in a double-blinded controlled
trial it was found that Coccinia indica (advocated by
Ayurveda) improved glucose tolerance in patients with
type 2 DM, as 10 out of 16 patients showed signiﬁcantly
(p<0.001) improved blood glucose levels following its
administration.9 Animal studies have also suggested that
this product may act in a similar manner to insulin.10 The
plant Tinospora cordifolia (heart-leaved moonseed, used in
the tropical regions of India) has been shown to increase
insulin secretion, thus bringing down blood glucose levels.
It has been demonstrated that aqueous and alcoholic
extracts of this plant seemed to increase glucose tolerance
in albino rats.11 Furthermore, in Ayurveda, Curcuma longa
(ivy gourd) is advocated extensively for treatment of DM,
and it was reported that C. longa had hypoglycemic prop-
erties in diabetic rats.12
Together, these studies show that there have been sev-
eral evidence-backed studies into AYUSH therapies for
managing DM. Perhaps the lack of “strong” scientiﬁc
evidence stated by doctors refers to the relatively few
human trials into these compounds. Moreover, the fact
that the exact side effects in these studies remain unknown
may make doctors more apprehensive about recommend-
ing them to their patients.
Our study has several implications for stakeholders,
including the government, doctors, research institutions
and patients. First, the fact that doctors in our study
believed that there was a lack of strong scientiﬁc evi-
dence for the use of AYUSH therapies implies that more
effort is required to conduct studies and publicize their
results. This would require increased funding and greater
motivation by research institutions to conduct larger scale
trials on human volunteers to test the efﬁcacy and safety
of the current AYUSH products. Second, 67% of doctors
in our study were completely unware of the Siddha form
of treatment and a further 62% were oblivious to Unani.
This implies that the ministry responsible for propagation
of AYUSH systems of healthcare needs to work in con-
junction with researchers to provide transparent and up-to
-date results of recent breakthroughs in the ﬁeld. They
must further ensure that their strategy to increase the
awareness of all components of AYUSH therapies
reaches doctors nationwide. Third, our study showed
several disparities compared to other trials in other
major cities in India regarding the awareness and effec-
tiveness of AYUSH therapies. We would therefore sug-
gest the establishment of a society for doctors based on
each specialty, including diabetologists, to ensure that
everyone is receiving the same information regarding
research into AYUSH therapies in their ﬁeld. Finally, it
must also be remembered that good health is not merely
the absence of disease but a “state of complete physical,
mental, and social well being.”13 Consequently, even if
the AYUSH therapies are not found to be effective in
reducing blood glucose levels in humans, studies must
continue to investigate their potential side effects. Indeed,
it may be possible that AYUSH therapies provide a form
of psychological and mental support for patients, and
with effective communication by doctors, adherence to
allopathic medication can be maintained. Several studies
have reported that compliance with antidiabetic medica-
tion in patients in India is poor.14,15
AYUSH systems of medicine have been used in India
for over 2000 years and several cultural groups still utilize
them today. However, research into these systems largely
remains in the preclinical phase. From the physicians
surveyed in this study, it seems that most are unaware of
what these systems advocate for the treatment of different
forms of diabetes. From this study, we may conclude that
greater efforts are required to conduct research into the
efﬁcacy and safety of AYUSH therapies to ensure that
doctors are able to provide holistic care and correct infor-
mation for patients with DM.
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